Tag: Chemotherapy

Progression-free, overall survival significantly lower for female patients receiving chemo mostly in morning

Benefits include histopathologic downstaging, fewer incomplete resections, and better two-year disease control

Physical function remains below that of age-matched controls even five years later

Findings seen among HR-positive, HER2-negative, node-negative early breast cancer patients with recurrence score of 11 to 25

Intervention during chemo linked to lower decreases in VO_2peak, health-related QoL, muscle strength immediately postchemotherapy

Men have lower rates of pathologic complete response than women across tumor subtypes

Greater CRF predicts increased pre- and postexertional static sway, while chemo-induced peripheral neuropathy does not

Authors say Gem/Doce warrants further study for the treatment of BCG-naive high-risk non-muscle-invasive bladder cancer

In Phase I/II trial of durvalumab with neoadjuvant chemo, pathological complete response rates similar for Black, non-Black patients

For patients with borderline resectable pancreatic ductal adenocarcinoma, favorable overall survival seen with eight cycles of mFOLFIRINOX